Hsieh F - Search Results

1

CRISPR screens for lipid regulators reveal a role for ER-bound SNX13 in lysosomal cholesterol export.

Lu A, Hsieh F, Sharma BR, Vaughn SR, Enrich C, Pfeffer SR. Lu A, et al. Among authors: hsieh f. J Cell Biol. 2022 Feb 7;221(2):e202105060. doi: 10.1083/jcb.202105060. Epub 2021 Dec 22. J Cell Biol. 2022. PMID: 34936700 Free PMC article.

2

Di-22:6-bis(monoacylglycerol)phosphate: A clinical biomarker of drug-induced phospholipidosis for drug development and safety assessment.

Liu N, Tengstrand EA, Chourb L, Hsieh FY. Liu N, et al. Toxicol Appl Pharmacol. 2014 Sep 15;279(3):467-476. doi: 10.1016/j.taap.2014.06.014. Epub 2014 Jun 23. Toxicol Appl Pharmacol. 2014. PMID: 24967688

3

A multiplexed UPLC-MS/MS assay for the simultaneous measurement of urinary safety biomarkers of drug-induced kidney injury and phospholipidosis.

Tengstrand E, Zhang H, Liu N, Dunn K, Hsieh F. Tengstrand E, et al. Among authors: hsieh f. Toxicol Appl Pharmacol. 2019 Mar 1;366:54-63. doi: 10.1016/j.taap.2019.01.012. Epub 2019 Jan 15. Toxicol Appl Pharmacol. 2019. PMID: 30653977 Free article.

4

Validation of a multiplexed LC-MS/MS clinical assay to quantify insulin-like growth factor-binding proteins in human serum and its application in a clinical study.

Liu N, Tengstrand E, Boernsen KO, Bek S, Hsieh F. Liu N, et al. Among authors: hsieh f. Toxicol Appl Pharmacol. 2019 May 15;371:74-83. doi: 10.1016/j.taap.2019.03.024. Epub 2019 Mar 26. Toxicol Appl Pharmacol. 2019. PMID: 30926377

5

Drug safety evaluation through biomarker analysis--a toxicity study in the cynomolgus monkey using an antibody-cytotoxic conjugate against ovarian cancer.

Hsieh FY, Tengstrand E, Lee JW, Li LY, Silverman L, Riordan B, Miwa G, Milton M, Alden C, Lee F. Hsieh FY, et al. Toxicol Appl Pharmacol. 2007 Oct 1;224(1):12-8. doi: 10.1016/j.taap.2007.06.009. Epub 2007 Jun 29. Toxicol Appl Pharmacol. 2007. PMID: 17681578

6

Bis(monoacylglycerol)phosphate as a non-invasive biomarker to monitor the onset and time-course of phospholipidosis with drug-induced toxicities.

Tengstrand EA, Miwa GT, Hsieh FY. Tengstrand EA, et al. Expert Opin Drug Metab Toxicol. 2010 May;6(5):555-70. doi: 10.1517/17425251003601961. Expert Opin Drug Metab Toxicol. 2010. PMID: 20370598 Review.

7

Higher Urine bis(Monoacylglycerol)Phosphate Levels in LRRK2 G2019S Mutation Carriers: Implications for Therapeutic Development.

Alcalay RN, Hsieh F, Tengstrand E, Padmanabhan S, Baptista M, Kehoe C, Narayan S, Boehme AK, Merchant K. Alcalay RN, et al. Among authors: hsieh f. Mov Disord. 2020 Jan;35(1):134-141. doi: 10.1002/mds.27818. Epub 2019 Sep 10. Mov Disord. 2020. PMID: 31505072 Free PMC article.

8

Biomarkers to monitor drug-induced phospholipidosis.

Baronas ET, Lee JW, Alden C, Hsieh FY. Baronas ET, et al. Toxicol Appl Pharmacol. 2007 Jan 1;218(1):72-8. doi: 10.1016/j.taap.2006.10.015. Epub 2006 Oct 26. Toxicol Appl Pharmacol. 2007. PMID: 17156806

9

Elucidation of potential bortezomib response markers in mutliple myeloma patients.

Hsieh FY, Tengstrand E, Pekol TM, Guerciolini R, Miwa G. Hsieh FY, et al. J Pharm Biomed Anal. 2009 Jan 15;49(1):115-22. doi: 10.1016/j.jpba.2008.09.053. Epub 2008 Oct 17. J Pharm Biomed Anal. 2009. PMID: 19062221

10

Toxicological protein biomarker analysis--an investigative one-week single dose intravenous infusion toxicity and toxicokinetic study in cynomolgus monkeys using an antibody-cytotoxic conjugate against ovarian cancer.

Hsieh FY, Tengstrand E, Li LY, Huang YN, Milton MN, Silverman L, Alden C, Miwa G, Lee F. Hsieh FY, et al. Pharm Res. 2008 Jun;25(6):1309-17. doi: 10.1007/s11095-007-9485-z. Pharm Res. 2008. PMID: 18060481

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

695 results

Search Page

Filters